×
About 6,336 results

ALLMedicine™ Burkholderia Center

Research & Reviews  3,079 results

Misidentification of Burkholderia pseudomallei, China.
https://doi.org/10.3201/eid2703.191769
Emerging Infectious Diseases; Wu B, Tong X et. al.

Feb 24th, 2021 - We report a case of melioidosis in China and offer a comparison of 5 commercial detection systems for Burkholderia pseudomallei. The organism was misidentified by the VITEK 2 Compact, Phoenix, VITEK mass spectrometry, and API 20NE systems but was ...

The lymphatic system as a potential mechanism of spread of melioidosis following ingest...
https://doi.org/10.1371/journal.pntd.0009016
PLoS Neglected Tropical Diseases; Nelson M, Nunez A et. al.

Feb 22nd, 2021 - Burkholderia pseudomallei is the causative agent of melioidosis, which is a Gram negative, facultative intracellular bacterium. Disease is prevalent in SE Asia and in northern Australia, as well as in other tropical and subtropical regions. Recent...

Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast T...
https://doi.org/10.1128/AAC.02230-20
Antimicrobial Agents and Chemotherapy; Fen SHY, Tandhavanant S et. al.

Feb 17th, 2021 - Melioidosis is an often fatal infection in tropical regions caused by an environmental bacterium, Burkholderia pseudomallei Current recommended melioidosis treatment requires intravenous β-lactam antibiotics such as ceftazidime (CAZ), meropenem (M...

In Vitro and In Vivo Characterization of Tebipenem (TBP), an Orally Active Carbapenem, ...
https://doi.org/10.1128/AAC.02385-20
Antimicrobial Agents and Chemotherapy; Clayton NP, Jain A et. al.

Feb 17th, 2021 - Bacillus anthracis and Yersinia pestis, causative pathogens for anthrax and plague, respectively, along with Burkholderia mallei and B. pseudomallei are potential bioterrorism threats. Tebipenem pivoxil hydrobromide (TBP HBr, formerly SPR994), is ...

see more →

Drugs  35 results see all →

Clinicaltrials.gov  3,167 results

Misidentification of Burkholderia pseudomallei, China.
https://doi.org/10.3201/eid2703.191769
Emerging Infectious Diseases; Wu B, Tong X et. al.

Feb 24th, 2021 - We report a case of melioidosis in China and offer a comparison of 5 commercial detection systems for Burkholderia pseudomallei. The organism was misidentified by the VITEK 2 Compact, Phoenix, VITEK mass spectrometry, and API 20NE systems but was ...

The lymphatic system as a potential mechanism of spread of melioidosis following ingest...
https://doi.org/10.1371/journal.pntd.0009016
PLoS Neglected Tropical Diseases; Nelson M, Nunez A et. al.

Feb 22nd, 2021 - Burkholderia pseudomallei is the causative agent of melioidosis, which is a Gram negative, facultative intracellular bacterium. Disease is prevalent in SE Asia and in northern Australia, as well as in other tropical and subtropical regions. Recent...

Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast T...
https://doi.org/10.1128/AAC.02230-20
Antimicrobial Agents and Chemotherapy; Fen SHY, Tandhavanant S et. al.

Feb 17th, 2021 - Melioidosis is an often fatal infection in tropical regions caused by an environmental bacterium, Burkholderia pseudomallei Current recommended melioidosis treatment requires intravenous β-lactam antibiotics such as ceftazidime (CAZ), meropenem (M...

In Vitro and In Vivo Characterization of Tebipenem (TBP), an Orally Active Carbapenem, ...
https://doi.org/10.1128/AAC.02385-20
Antimicrobial Agents and Chemotherapy; Clayton NP, Jain A et. al.

Feb 17th, 2021 - Bacillus anthracis and Yersinia pestis, causative pathogens for anthrax and plague, respectively, along with Burkholderia mallei and B. pseudomallei are potential bioterrorism threats. Tebipenem pivoxil hydrobromide (TBP HBr, formerly SPR994), is ...

see more →

News  55 results

MPM Medical LLC Issues Voluntary Nationwide Recall of Regenecare HA Hydrogel Due to Burkholderia cepecia Contamination | FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mpm-medical-llc-issues-voluntary-nationwide-recall-regenecare-ha-hydrogel-due-burkholderia-cepecia

Summary Company Announcement Date: December 02, 2020 FDA Publish Date: December 02, 2020 Product Type: Drugs Reason for Announcement: Recall Reason Description Burkholderia cepecia contamination. Company Name: MPM Medical, LLC Brand Name: Brand Na...

Centurion Labs Issues Voluntary Nationwide Recall of Ninjacof (Lot # 200N1601) and Ninjacof A (Lot# 201NA1601) Products Due to Potential Burkholderia Cepacia Contamination | FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/centurion-labs-issues-voluntary-nationwide-recall-ninjacof-lot-200n1601-and-ninjacof-lot-201na1601

Summary Company Announcement Date: August 22, 2017 FDA Publish Date: February 06, 2018 Product Type: Drugs Food & Beverages Generic Drugs Reason for Announcement: Recall Reason Description Potential contamination with Burkholderia cepacia Company ...

Mid Valley Pharmaceutical LLC Issues Voluntary Recall of Doctor Manzanilla Cough & Cold and Doctor Manzanilla Allergy & Decongestant Relief Syrup Due to Potential Contamination with Burkholderia Ce...
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mid-valley-pharmaceutical-llc-issues-voluntary-recall-doctor-manzanilla-cough-cold-and-doctor

Summary Company Announcement Date: August 30, 2017 FDA Publish Date: February 08, 2018 Product Type: Drugs Generic Drugs Reason for Announcement: Recall Reason Description Burkholderia Cepacia Company Name: Mid Valley Pharmaceutical Brand Name: Br...

Mavidon Issues Voluntary Worldwide Recall of Manufactured Products Including Lemonprep® Tubes And Single Use Cups Pediaprep® Tubes And Single Use Cups Wave Prep® Tubes And Single Use Cups Cardio Pr...
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mavidon-issues-voluntary-worldwide-recall-manufactured-products-including-lemonprepr-tubes-and

Summary Company Announcement Date: December 23, 2019 FDA Publish Date: January 08, 2020 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Burkholderia cepacia Company Name: Mavidon Brand Name: Brand Name(s) LemonPrep...

Anti-Migraine Drug Recalled Due to Potential Contamination
https://www.medscape.com/viewarticle/917018

Aug 18th, 2019 - Pfizer is recalling two lots of eletriptan hydrobromide (Relpax) 40-mg tablets because of potential contamination with Pseudomonas and Burkholderia bacteria, the company has announced. The drug is indicated for the acute treatment of migraine with...

see more →